2015
DOI: 10.1016/j.jbi.2015.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Utilizing social media data for pharmacovigilance: A review

Abstract: Objective Automatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient outcomes caused by medications, is a challenging research problem that is currently receiving significant attention from the medical informatics community. In recent years, user-posted data on social media, primarily due to its sheer volume, has become a useful resource for ADR monitoring. Research using social media data has progressed using various data sources and techniques, making it difficult to compare distinct s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
331
1
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 415 publications
(336 citation statements)
references
References 36 publications
2
331
1
2
Order By: Relevance
“…2 PCORnet is the National Patient-Centered Clinical Research Network that integrates health data for studies and catalyzes research partnerships among two types of networks: (1) Clinical Data Research Networks (CDRNs), which are mainly based in healthcare systems such as hospitals and health centers, and (2) PPRNs, which are run by groups of patients and their partners who are focused on one or more specific conditions or communities, and who are interested in sharing health information and participating in research. 39 The PCORnet networks have developed multi-dimensional methods and approaches for engaging patients to provide input into their networks and studies. For example, networks have a variety of structures for engaging patients, caregivers, and patient advocates in the governance of their networks to help make critical decisions with respect to planning and operationalizing the network and their respective research priorities.…”
Section: Methods Of Engaging Patient Stakeholdersmentioning
confidence: 99%
See 3 more Smart Citations
“…2 PCORnet is the National Patient-Centered Clinical Research Network that integrates health data for studies and catalyzes research partnerships among two types of networks: (1) Clinical Data Research Networks (CDRNs), which are mainly based in healthcare systems such as hospitals and health centers, and (2) PPRNs, which are run by groups of patients and their partners who are focused on one or more specific conditions or communities, and who are interested in sharing health information and participating in research. 39 The PCORnet networks have developed multi-dimensional methods and approaches for engaging patients to provide input into their networks and studies. For example, networks have a variety of structures for engaging patients, caregivers, and patient advocates in the governance of their networks to help make critical decisions with respect to planning and operationalizing the network and their respective research priorities.…”
Section: Methods Of Engaging Patient Stakeholdersmentioning
confidence: 99%
“…In addition, evidence for COAs must include data to demonstrate that the clinical outcome is linked to survival or how patients feel or function in daily life. 39 While these guidelines are not directly applicable to registry research, both patient-reported and clinical outcome measures used in registries should likewise show evidence of importance to the patient population through patient review and testing of the measure for relevance of content and cognitive and linguistic understanding.…”
Section: Overall Registry Processmentioning
confidence: 99%
See 2 more Smart Citations
“…Use of such information is an emerging trend and has support and evidence of being able to bring real time information from actual users to clinicians, bridging the current gap in our scientific knowledge [40][41][42]. Here we supplemented existing literature with real-time information from social media to provide the most up-to-date coverage of the topic and extend beyond our existing clinical knowledge.…”
Section: Discussionmentioning
confidence: 99%